Administration of Imatinib Mesylate Attenuates Renal Fibrosis in Mice
LIU Wei,LIU Xiao-cheng,ZHAO Xiao-qin,HE Xiao-feng,SHAO Ju-fang
DOI: https://doi.org/10.3870/j.issn.1004-0781.2008.02.010
2008-01-01
Abstract:Objective To evaluate the effect of Imatinib mesylate(STI571) on the process of renal interstitial fibrosis following unilateral ureteral obstruction in mice. Methods 40 male mice were randomly assigned to four groups: sham operation group,UUO group,and UUO treatment group in which mice receiving 80,160 mg·kg-1·d-1 STI571after operation.All mice were killed at the 8th day after operation.Renal tissue histological changes were observed.The content of total collagen from each group was examined by acidolysis and chromatometry.Meanwhile,the de novo expression of α-smooth muscle actin(α-SMA)、proliferating cell nuclear antigen(PCNA) and fibronectin(FN) in tissues were assessed by immunohistochemistry. Results Compared to UUO group,Imatinib mesylate significantly ameliorated the histological changes of the UUO renal tissue.The expression of α-SMA、PCNA and FN were decreased significantly in the treatment groups. Conclusion Imatinib mesylate could downregulate the expression of α-SMA、PCNA and FN in the UUO mice.It suppresses the proliferation and activation of renal interstitial cells and reduces the deposition of extracellular matrix in the interstitium as well.This demonstrates that Imatinib mesylate possesses the potential ability to inhibit early renal interstitium fibrosis caused by UUO in mice.
What problem does this paper attempt to address?